Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,700 | 219,500 | 41,600 | 74,300 | 69,700 |
| Depreciation Amortization | 31,900 | 169,600 | 97,700 | 63,900 | 29,700 |
| Income taxes - deferred | 1,900 | 46,000 | 600 | -3,200 | -1,700 |
| Accounts receivable | 93,700 | -16,200 | -114,700 | -34,700 | 42,100 |
| Accounts payable and accrued liabilities | -14,700 | -1,600 | 3,500 | 8,000 | 20,100 |
| Other Working Capital | -76,400 | -145,000 | -273,900 | -185,600 | -107,700 |
| Other Operating Activity | -70,000 | 47,900 | 237,300 | 52,700 | -47,100 |
| Operating Cash Flow | $-37,300 | $320,200 | $-7,900 | $-24,600 | $5,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32,200 | -224,100 | -178,300 | -123,100 | -56,100 |
| Investing Cash Flow | $-32,200 | $-224,100 | $-178,300 | $-123,100 | $-56,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -8,500 | -25,300 | -16,900 | -11,300 | -16,200 |
| Debt Repayment | N/A | -10,600 | -10,600 | -10,600 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 6,900 |
| Common Stock Repurchased | -57,500 | -106,000 | N/A | N/A | N/A |
| Other Financing Activity | -4,500 | 900 | -3,500 | -4,100 | -12,900 |
| Financing Cash Flow | $-70,500 | $-141,000 | $-31,000 | $-26,000 | $-22,200 |
| Exchange Rate Effect | -300 | -300 | -300 | -100 | -300 |
| Beginning Cash Position | 576,300 | 621,500 | 621,500 | 621,500 | 621,500 |
| End Cash Position | 436,000 | 576,300 | 404,000 | 447,700 | 548,000 |
| Net Cash Flow | $-140,300 | $-45,200 | $-217,500 | $-173,800 | $-73,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,300 | 320,200 | -7,900 | -24,600 | 5,100 |
| Capital Expenditure | -32,200 | -224,100 | -178,300 | -123,100 | -56,100 |
| Free Cash Flow | -69,500 | 96,100 | -186,200 | -147,700 | -51,000 |